SELLAS Life Sciences (SLS) FCF Margin (2012 - 2022)

SELLAS Life Sciences (SLS) reported FCF Margin of 715.0% for Q1 2022, down 53484.0% year-over-year from N/an in Q1 2021, and down 177.36% on a QoQ basis from 257.79% in Q2 2021.

SELLAS Life Sciences (SLS) has 7 years of FCF Margin data on file, last reported at 715.0% in Q1 2022.

  • Quarterly FCF Margin fell 53484.0% year-over-year to 715.0% in Q1 2022, while the trailing twelve-month figure through Dec 2022 was 2380.9% (down 203852.0% YoY) and the FY2022 annual result came in at 2380.9%, down 203852.0% from the prior year.
  • FCF Margin declined to 715.0% in Q1 2022 per SLS's latest filing, from 257.79% in the prior quarter.
  • Across five years, FCF Margin topped out at 180.21% in Q4 2020 and bottomed at 715.0% in Q1 2022.
  • The 3-year median for FCF Margin is 218.97% (2021), against an average of 243.18%.
  • Peak annual rise in FCF Margin reached 53484 bps in 2022, while the deepest fall reached 53484 bps in 2022.
  • Tracing SLS's FCF Margin over 3 years: stood at 180.21% in 2020, then plunged by 243 bps to 257.79% in 2021, then tumbled by 177 bps to 715.0% in 2022.
  • Per Business Quant, the three latest SLS FCF Margin figures stand at 715.0% (Q1 2022), 257.79% (Q2 2021), and 180.16% (Q1 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -3.98%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 43.35%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 23.53%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 4.17%
10 SELLAS Life Sciences 1.61 Bn 1.61 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2022 -715.00%
Jun 30, 2021 -257.79%
Mar 31, 2021 -180.16%
Dec 31, 2020 180.21%
Jun 30, 2015 -265.32%
Mar 31, 2015 -399.89%
Dec 31, 2014 -259.87%
Sep 30, 2014 -477.90%
Jun 30, 2014 -556.80%
Mar 31, 2014 -371.38%
Dec 31, 2013 -81.53%
Sep 30, 2013 -499.20%
Jun 30, 2013 -305.58%
Mar 31, 2013 -245.33%
Dec 31, 2012 442.56%
Sep 30, 2012 -355.98%